Global Gonorrhea Diagnostics Market 2016-2020

  • ID: 3769311
  • Report
  • Region: Global
  • 62 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Beckman Coulter
  • Diamedix
  • Mackay Life Sciences
  • Qiagen
  • Sequenom
  • MORE
About the Gonorrhea Diagnostics Market

Gonorrhea is a sexually transmitted disease that can affect both males and females. It is caused by the bacterium Neisseria gonorrhoeae. The bacterium grows in warm and moist areas of uterus, reproductive tract, fallopian tubes, and urethra. It can also grow and infect the throat, mouth, and anus. Women are more likely to contract this disease than men. Based on the Sexually Transmitted Disease Surveillance 2009 report, the Centers for Disease Control and Prevention (CDC) estimated that gonorrhea is the second most common communicable disease in the US.

The analysts forecast the global gonorrhea diagnostics market to grow at a CAGR of 9.25% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global gonorrhea diagnostics market for 2016-2020. To calculate the market size, Technavio uses revenue generated from the sales of gonorrhea diagnostics products.

The market is divided into the following segments based on geography:

- Americas
- APAC
- EMEA

The report, Global Gonorrhea Diagnostics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Abbott Laboratories
- Beckman Coulter
- Roche Diagnostics
- Siemens

Other prominent vendors
- Agilent Technologies
- Alere
- Becton Dickinson and Company
- Bio-Rad
- Cepheid
- Diamedix
- Kyowa Medex
- Lonza
- Mackay Life Sciences
- Nihon Kohden
- Ortho-Clinical Diagnostics
- Polymedco
- Qiagen
- SDIX
- Sequenom
- Sienco
- Sysmex
- Takara Bio
- Thermo Fisher

Market drivers
- Increase incidence of gonorrhea

Market challenges
- Lack of technical expertise

Market trends
- Growing use of molecular diagnostics

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Beckman Coulter
  • Diamedix
  • Mackay Life Sciences
  • Qiagen
  • Sequenom
  • MORE
PART 01: Executive summary
  • Highlights
PART 02: Scope of the report
  • Market overview
  • Top-vendor offerings
PART 03: Market research methodology
  • Research methodology
  • Economic indicators
PART 04: Introduction
  • Key market highlights
  • Gonorrhea: An overview
  • Etiology of gonorrhea
  • Symptoms and incubation period of gonorrhea
  • Methods of collection of specimens for the diagnosis of gonorrhea
  • Complications of untreated gonorrhea
  • Patient counselling
PART 05: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
PART 06: Cost analysis

PART 07: Market segmentation by application
  • Chromatography
  • Diagnostic imaging
  • Differential light scattering
  • Flow cytometry
  • Gel microdroplets
  • Immunoassay
  • Molecular diagnostics
  • Monoclonal antibodies test
PART 08: Geographical segmentation
  • Gonorrhea diagnostics market in Americas
  • Gonorrhea diagnostics market in EMEA
  • Gonorrhea diagnostics market in APAC
PART 09: Key leading countries
  • US
  • Germany
  • Japan
PART 10: Buying criteria
  • Key
PART 11: Market drivers
  • Increase in incidence of gonorrhea
  • Significant growth in emerging countries
  • Increase in patient awareness
  • Improvement in healthcare infrastructure
PART 12: Impact of drivers

PART 13: Market challenges
  • Issues in regulatory framework
  • Intense competition among vendors
  • Lack of technical expertise
PART 14: Impact of drivers and challenges

PART 15: Market trends
  • Technological advancements
  • Growing use of molecular diagnostics
  • Increase in M&A
PART 16: Vendor landscape
  • Competitive scenario
PART 17: Key vendor analysis
  • Abbott Laboratories
  • Beckman Coulter
  • Roche Diagnostics
  • Siemens
  • Other prominent vendors
PART 18: Appendix
  • List of abbreviations
PART 19: About the Author

List of Exhibits

Exhibit 01: Product offerings
Exhibit 02: Symptoms and incubation period of gonorrhea
Exhibit 03: Average duration of infection for gonorrhea
Exhibit 04: Methods of collection of specimens in different parts of the body
Exhibit 05: Complications of untreated gonorrhea
Exhibit 06: Patient counselling
Exhibit 07: Global gonorrhea diagnostics market 2015-2020 in ($ billions)
Exhibit 08: Five forces analysis
Exhibit 09: Segmentation of global gonorrhea diagnostics market based on the application
Exhibit 10: Global gonorrhea diagnostics market 2015 (%)
Exhibit 11: Global gonorrhea diagnostics market 2020 (%)
Exhibit 12: Gonorrhea diagnostics market in Americas 2015-2020 ($ billions)
Exhibit 13: Gonorrhea diagnostics market in EMEA 2015-2020 ($ billions)
Exhibit 14: Gonorrhea diagnostics market in APAC 2015-2020 ($ billions)
Exhibit 15: Global gonorrhea diagnostics market by geography 2015-2020 ($ millions)
Exhibit 16: Global gonorrhea diagnostics market by geography (%)
Exhibit 17: Reported cases of gonorrhea based on age group in US in 2014 (CDC)
Exhibit 18: Rates of reported cases of gonorrhea by age and gender in US 2014
Exhibit 19: Reported cases of gonorrhea in US from 2010-2014 (in thousands)
Exhibit 20: Reported cases of gonorrhea among women in US 2010-2014
Exhibit 21: Reported cases of gonorrhea among men 2010-2014
Exhibit 22: Buying criteria for global gonorrhea diagnostics market
Exhibit 23: Impact of drivers
Exhibit 24: Impact of drivers and challenges
Exhibit 25: Abbott Laboratories: Product portfolio
Exhibit 26: Abbott Laboratories: Diagnostic segment by revenue 2013-2015 ($ billions)
Exhibit 27: Abbott Laboratories: Key takeaways
Exhibit 28: Product portfolio
Exhibit 29: Beckman Coulter: Key takeaways
Exhibit 30: Product portfolio
Exhibit 31: Molecular diagnostics 2013-2015 ($ billions)
Exhibit 32: Roche Diagnostics: Key takeaways
Exhibit 33: Product portfolio
Exhibit 34: Siemens: Healthcare segment by revenue 2013-2015 ($ billions)
Exhibit 35: Siemens: Key takeaways
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Beckman Coulter
  • Diamedix
  • Mackay Life Sciences
  • Qiagen
  • Sequenom
  • MORE
New Report Released: - Global Gonorrhea Diagnostics Market 2016-2020

The author of the report recognizes the following companies as the key players in the global gonorrhea diagnostics market: Abbott Laboratories, Beckman Coulter, Roche Diagnostics, and Siemens.

Other Prominent Vendors in the market are: Agilent Technologies, Alere, Becton Dickinson and Company, Bio-Rad, Cepheid, Diamedix, Kyowa Medex, Lonza, Mackay Life Sciences, Nihon Kohden, Ortho-Clinical Diagnostics, Polymedco, Qiagen, SDIX, Sequenom, Sienco, Sysmex, Takara Bio, and Thermo Fisher.

Commenting on the report, an analyst from the research team said: “A trend which is already contributing to market growth is the growing use of molecular diagnostics. Molecular diagnostics are used to study the chemical structure of DNA to determine the presence of an abnormal gene sequences, which could be the potential cause for the disease caused by an organism or pathogen. Therefore, physicians can isolate the specific gene polymorphisms causing the disease directly, or indirectly target DNA through amplification based on the amount of target DNA present. Molecular diagnostics represent the first step toward understanding a disease at the molecular level and is the fastest-growing clinical diagnostics technology.”

According to the report, a key growth driver is the rising number of gonorrhea cases. The incidence of gonorrhea has been on the rise worldwide. According to the CDC, gonorrhea is the second most commonly reported communicable disease after chlamydia. In 2014, as per the estimates by CDC, there were around 350,062 reported cases of gonorrhea (a rate of 110.7 per 100,000) in the US. The highest incidence of gonorrhea was observed in heterosexually infected men, especially those aged 25-34 years. During the last 10 years, women constituted only around 20%-30% of all the reported cases of gonorrhea.

Further, the report states that one challenge that could restrict market growth is the lack of technical expertise. Gonorrhea diagnosis is highly complex and technical. An expert such as a specialized medical practitioner is required that can provide accurate and specific results to the patient.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
- Abbott Laboratories
- Beckman Coulter
- Roche Diagnostics
- Siemens
- Agilent Technologies
- Alere
- Becton Dickinson and Company
- Bio-Rad
- Cepheid
- Diamedix
- Kyowa Medex
- Lonza
- Mackay Life Sciences
- Nihon Kohden
- Ortho-Clinical Diagnostics
- Polymedco
- Qiagen
- SDIX
- Sequenom
- Sienco
- Sysmex
- Takara Bio
- Thermo Fisher.
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll